Le SIDA en Afrique subsaharienne (serveur d'exploration) - Analysis (RSA)

Index « Auteurs » - entrée « Christopher J. Hoffmann »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Christopher J. Colvin < Christopher J. Hoffmann < Christopher Jack  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000186 (2017) Clement G. Adu-Gyamfi ; Tracy Snyman [Afrique du Sud] ; Christopher J. Hoffmann [États-Unis] ; Neil A. Martinson [Afrique du Sud] ; Richard E. Chaisson [États-Unis] ; Jaya A. George [Afrique du Sud] ; Melinda S. SuchardPlasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients.
000210 (2017) John Gregson [Royaume-Uni] ; Pontiano Kaleebu [Ouganda] ; Vincent C. Marconi [États-Unis] ; Cloete Van Vuuren [Afrique du Sud] ; Nicaise Ndembi [Nigeria] ; Raph L. Hamers [Pays-Bas] ; Phyllis Kanki [États-Unis] ; Christopher J. Hoffmann [États-Unis] ; Shahin Lockman [États-Unis] ; Deenan Pillay [Afrique du Sud] ; Tulio De Oliveira [Afrique du Sud] ; Nathan Clumeck [Belgique] ; Gillian Hunt [Afrique du Sud] ; Bernhard Kerschberger [Swaziland] ; Robert W. Shafer [États-Unis] ; Chunfu Yang [États-Unis] ; Elliot Raizes [États-Unis] ; Rami Kantor [États-Unis] ; Ravindra K. Gupta [Afrique du Sud]Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study.
000215 (2017) Soo-Yon Rhee [États-Unis] ; Vici Varghese [États-Unis] ; Susan P. Holmes [États-Unis] ; Gert U. Van Zyl [Afrique du Sud] ; Kim Steegen [Afrique du Sud] ; Mark A. Boyd [Australie] ; David A. Cooper [Australie] ; Sabin Nsanzimana [Rwanda] ; Shanmugam Saravanan [Inde] ; Charlotte Charpentier [France] ; Tulio De Oliveira [Afrique du Sud] ; Mary-Ann A. Etiebet [États-Unis] ; Federico Garcia [Espagne] ; Dominique Goedhals [Afrique du Sud] ; Perpetua Gomes [Portugal] ; Huldrych F. Günthard [Suisse] ; Raph L. Hamers [Pays-Bas] ; Christopher J. Hoffmann [États-Unis] ; Gillian Hunt [Afrique du Sud] ; Awachana Jiamsakul [Australie] ; Pontiano Kaleebu [Ouganda] ; Phyllis Kanki [États-Unis] ; Rami Kantor [États-Unis] ; Bernhard Kerschberger [Swaziland] ; Vincent C. Marconi [États-Unis] ; Jean D'Amour Ndahimana [Rwanda] ; Nicaise Ndembi [Nigeria] ; Nicole Ngo-Giang-Huong [France] ; Casper Rokx [Pays-Bas] ; Maria M. Santoro [Italie] ; Jonathan M. Schapiro [Israël] ; Daniel Schmidt [Allemagne] ; Lillian Seu [États-Unis] ; Kim C E. Sigaloff [Pays-Bas] ; Sunee Sirivichayakul [Thaïlande] ; Lindiwe Skhosana [Afrique du Sud] ; Henry Sunpath [Afrique du Sud] ; Michele Tang [États-Unis] ; Chunfu Yang [Haïti] ; Sergio Carmona [Afrique du Sud] ; Ravindra K. Gupta [Royaume-Uni] ; Robert W. Shafer [États-Unis]Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration.
000289 (2017) Michael J. Vinikoor ; Edford Sinkala ; Roma Chilengi ; Lloyd B. Mulenga ; Benjamin H. Chi [États-Unis] ; Zude Zyambo ; Christopher J. Hoffmann [États-Unis] ; Michael S. Saag ; Mary-Ann Davies [Afrique du Sud] ; Matthias Egger [Suisse] ; Gilles Wandeler [Suisse]Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia.
000366 (2017) Akshay N. Gupte [États-Unis] ; Michelle L. Wong [Afrique du Sud] ; Reginah Msandiwa [Afrique du Sud] ; Grace L. Barnes [États-Unis] ; Jonathan Golub [États-Unis] ; Richard E. Chaisson [États-Unis] ; Christopher J. Hoffmann [États-Unis] ; Neil A. Martinson [Afrique du Sud]Factors associated with pulmonary impairment in HIV-infected South African adults.
000744 (2015) Leigh F. Johnson [Afrique du Sud] ; Rob E. Dorrington [Afrique du Sud] ; Ria Laubscher [Afrique du Sud] ; Christopher J. Hoffmann [Afrique du Sud, États-Unis] ; Robin Wood [Afrique du Sud] ; Matthew P. Fox [États-Unis, Afrique du Sud] ; Morna Cornell [Afrique du Sud] ; Michael Schomaker [Afrique du Sud] ; Hans Prozesky [Afrique du Sud] ; Frank Tanser [Afrique du Sud] ; Mary-Ann Davies [Afrique du Sud] ; Andrew Boulle [Afrique du Sud]A comparison of death recording by health centres and civil registration in South Africans receiving antiretroviral treatment
000A30 (2013) Leigh F. Johnson [Afrique du Sud] ; Joel Mossong [Afrique du Sud] ; Rob E. Dorrington [Afrique du Sud] ; Michael Schomaker [Afrique du Sud] ; Christopher J. Hoffmann [Afrique du Sud, États-Unis] ; Olivia Keiser [Suisse] ; Matthew P. Fox [États-Unis, Afrique du Sud] ; Robin Wood [Afrique du Sud] ; Hans Prozesky [Afrique du Sud] ; Janet Giddy [Afrique du Sud] ; Daniela Belen Garone [Afrique du Sud] ; Morna Cornell [Afrique du Sud] ; Matthias Egger [Suisse] ; Andrew Boulle [Afrique du Sud]Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies
000A54 (2013) Michael Schomaker [Afrique du Sud] ; Matthias Egger ; Mhairi Maskew ; Daniela Garone ; Hans Prozesky ; Christopher J. Hoffmann ; Andrew Boulle ; Lukas FennerImmune recovery after starting ART in HIV-infected patients presenting and not presenting with tuberculosis in South Africa.
000D14 (2012) Craig Innes [Afrique du Sud] ; Robin Hamilton [Afrique du Sud] ; Christopher J. Hoffmann [Afrique du Sud, États-Unis] ; Piotr Hippner [Afrique du Sud] ; Katherine Fielding [Royaume-Uni] ; Alison D. Grant [Royaume-Uni] ; Gavin J. Churchyard [Afrique du Sud] ; Salome Charalambous [Afrique du Sud]A novel HIV treatment model using private practitioners in South Africa
000F41 (2010) Christopher J. Hoffmann [Afrique du Sud] ; Katherine L. Fielding ; Salome Charalambous ; Craig Innes ; Richard E. Chaisson ; Alison D. Grant ; Gavin J. ChurchyardReducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa.
001094 (2010) Salome Charalambous [Afrique du Sud] ; Alison D. Grant ; Craig Innes ; Christopher J. Hoffmann ; Rob Dowdeswell ; Jan Pienaar ; Katherine L. Fielding ; Gavin J. ChurchyardAssociation of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme.

List of associated KwdEn.i

Nombre de
documents
Descripteur
6Female
6Humans
6Male
5Adult
5CD4 Lymphocyte Count
5HIV Infections (drug therapy)
3Anti-HIV Agents (therapeutic use)
3HIV Infections (mortality)
3Middle Aged
3South Africa (epidemiology)
3Viral Load
2Antiretroviral Therapy, Highly Active
2Cohort Studies
2HIV Infections (complications)
2HIV Infections (immunology)
2HIV-1
2Risk Factors
2South Africa
2Tuberculosis (drug therapy)
1AIDS-Related Opportunistic Infections (complications)
1AIDS-Related Opportunistic Infections (drug therapy)
1AIDS-Related Opportunistic Infections (immunology)
1AIDS-Related Opportunistic Infections (mortality)
1AIDS-Related Opportunistic Infections (prevention & control)
1Acceptable results
1Adherence counselling
1Adverse effects
1Adverse events
1Africa South of the Sahara
1Age Factors
1Anti-Infective Agents (administration & dosage)
1Anti-Infective Agents (therapeutic use)
1Anti-Retroviral Agents (adverse effects)
1Anti-Retroviral Agents (therapeutic use)
1Antibiotic Prophylaxis (methods)
1Antiretroviral
1Antiretroviral Therapy, Highly Active (mortality)
1Antiretroviral therapy
1Antiretroviral treatment
1Antiretroviral treatment programmes
1Antitubercular Agents (therapeutic use)
1Aurum institute
1Baseline
1Benzoxazines (pharmacology)
1Benzoxazines (therapeutic use)
1Cohort
1Cohort analysis
1Counselling
1Data collection
1Data entry
1Data management
1Drug Administration Schedule
1Drug Resistance, Viral (drug effects)
1Drug Resistance, Viral (genetics)
1Epidemiologic Methods
1Guideline
1HIV Infections (prevention & control)
1HIV Seropositivity
1HIV-1 (drug effects)
1Health systems
1Health workers
1High attrition rate
1Human resources
1Incidence
1Isoniazid (therapeutic use)
1Lamivudine (pharmacology)
1Lamivudine (therapeutic use)
1Life Expectancy
1Logistic Models
1London school
1Lung Diseases, Obstructive (complications)
1Lung Diseases, Obstructive (epidemiology)
1Manuscript development
1Median
1Medical doctors
1Mutation (genetics)
1Nevirapine (therapeutic use)
1Opportunistic infections
1Other reasons
1Patient requests
1Pharmacy control
1Practitioner
1Practitioner programme
1Private practitioner
1Private practitioner model
1Private practitioner programme
1Private practitioner sites
1Private practitioners
1Private sector
1Programme
1Proportional Hazards Models
1Protocol development
1Public sector
1Regimen
1Results show
1Retrospective Studies
1Reverse Transcriptase Inhibitors (therapeutic use)
1Service models table
1Sex Factors
1Smoking

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/RSA/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/RSA/Analysis/Author.i -k "Christopher J. Hoffmann" 
HfdIndexSelect -h $EXPLOR_AREA/Data/RSA/Analysis/Author.i  \
                -Sk "Christopher J. Hoffmann" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/RSA/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    RSA
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Christopher J. Hoffmann
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024